{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:14:24Z","timestamp":1790486064154,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41375-018-0082-4","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T12:04:58Z","timestamp":1519819498000},"page":"2412-2426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations"],"prefix":"10.1038","volume":"32","author":[{"given":"V.","family":"Pillonel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Juskevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6100-0026","authenticated-orcid":false,"given":"C. K. Y.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bodmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zettl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dirnhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-3819","authenticated-orcid":false,"given":"A.","family":"Tzankov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"key":"82_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-3-319-13150-4_9","volume":"165","author":"B Vannata","year":"2015","unstructured":"Vannata B, Stathis A, Zucca E. Management of the marginal zone lymphomas. Cancer Treat Res. 2015;165:227\u201349.","journal-title":"Cancer Treat Res"},{"key":"82_CR2","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2017.","edition":"4th ed"},{"key":"82_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.beha.2016.11.001","volume":"30","author":"S Pileri","year":"2017","unstructured":"Pileri S, Ponzoni M. Pathology of nodal marginal zone lymphomas. Best Pract Res Clin Haematol. 2017;30:50\u20135.","journal-title":"Best Pract Res Clin Haematol"},{"key":"82_CR4","first-page":"92","volume":"26","author":"A Traverse-Glehen","year":"2012","unstructured":"Traverse-Glehen A, Bertoni F, Thieblemont C, Zucca E, Coiffier B, Berger F, et al. Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma. Oncology (Williston Park). 2012;26:92\u20139. 103\u20134","journal-title":"Oncology (Williston Park)"},{"key":"82_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.beha.2016.08.026","volume":"30","author":"T Tadmor","year":"2017","unstructured":"Tadmor T. Nodal marginal zone lymphoma: clinical features, diagnosis, management and treatment. Best Pract Res Clin Haematol. 2017;30:92\u20138.","journal-title":"Best Pract Res Clin Haematol"},{"key":"82_CR6","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3324\/haematol.2012.083386","volume":"98","author":"M Brand van den","year":"2013","unstructured":"van den Brand M, Han J, van Krieken JM. Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review. Haematologica. 2013;98:1003\u201313.","journal-title":"Haematologica"},{"key":"82_CR7","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","volume":"117","author":"A Rinaldi","year":"2011","unstructured":"Rinaldi A, Mian M, Chigrinova E, Arcaini L, Bhagat G, Novak U, et al. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood. 2011;117:1595\u2013604.","journal-title":"Blood"},{"key":"82_CR8","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","volume":"128","author":"V Spina","year":"2016","unstructured":"Spina V, Khiabanian H, Messina M, Monti S, Cascione L, Bruscaggin A, et al. The genetics of nodal marginal zone lymphoma. Blood. 2016;128:1362\u201373.","journal-title":"Blood"},{"key":"82_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.beha.2016.09.004","volume":"30","author":"V Spina","year":"2017","unstructured":"Spina V, Rossi D. Molecular pathogenesis of splenic and nodal marginal zone lymphoma. Best Pract Res Clin Haematol. 2017;30:5\u201312.","journal-title":"Best Pract Res Clin Haematol"},{"key":"82_CR10","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","volume":"128","author":"V Spina","year":"2016","unstructured":"Spina V, Khiabanian H, Messina M, Monti S, Cascione L, Bruscaggin A, et al. The genetics of nodal marginal zone lymphoma. Blood. 2016;128:1362\u201373.","journal-title":"Blood"},{"key":"82_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/his.13015","volume":"70","author":"M Brand van den","year":"2017","unstructured":"van den Brand M, Rijntjes J, Hebeda KM, Menting L, Bregitha CV, Stevens WBC, et al. Recurrent mutations in genes involved in nuclear factor-\u03baB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications. Histopathology. 2017;70:174\u201384.","journal-title":"Histopathology"},{"key":"82_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/annonc\/mds643","volume":"24","author":"M Dreyling","year":"2013","unstructured":"Dreyling M, Thieblemont C, Gallamini A, Arcaini L, Campo E, Hermine O, et al. Esmo consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol. 2013;24:857\u201377.","journal-title":"Ann Oncol"},{"key":"82_CR13","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/modpathol.2013.214","volume":"27","author":"A Tzankov","year":"2014","unstructured":"Tzankov A, Xu-Monette ZY, Gerhard M, Visco C, Dirnhofer S, Gisin N, et al. Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol. 2014;27:958\u201371.","journal-title":"Mod Pathol"},{"key":"82_CR14","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0002-9440(10)63055-6","volume":"159","author":"VS Meier","year":"2001","unstructured":"Meier VS, Rufle A, Gudat F. Simultaneous evaluation of T- and B-cell clonality, t(11;14) and t(14;18), in a single reaction by a four-color multiplex polymerase chain reaction assay and automated high-resolution fragment analysis. Am J Pathol. 2001;159:2031\u201343.","journal-title":"Am J Pathol"},{"key":"82_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/sj.bjc.6602889","volume":"94","author":"EH Beers van","year":"2006","unstructured":"van Beers EH, Joosse Sa, Ligtenberg MJ, Fles R, Hogervorst FBL, Verhoef S, et al. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer. 2006;94:333\u20137.","journal-title":"Br J Cancer"},{"key":"82_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/PAS.0000000000000411","volume":"39","author":"A Martinez-Lopez","year":"2015","unstructured":"Martinez-Lopez A, Curiel-Olmo S, Mollejo M, Cereceda L, Martinez N, Montes-Moreno S, et al. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. Am J Surg Pathol. 2015;39:644\u201351.","journal-title":"Am J Surg Pathol"},{"key":"82_CR17","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754\u201360.","journal-title":"Bioinformatics"},{"key":"82_CR18","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"82_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31:213\u20139.","journal-title":"Nat Biotechnol"},{"key":"82_CR20","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders CT, Wong WSW, Swamy S, Becq J, Murray LJ, Cheetham RK. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics. 2012;28:1811\u20137.","journal-title":"Bioinformatics"},{"key":"82_CR21","first-page":"1","volume":"34","author":"MT Chang","year":"2015","unstructured":"Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, et al. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol. 2015;34:1\u201311.","journal-title":"Nat Biotechnol"},{"key":"82_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/path.4672","volume":"238","author":"S Piscuoglio","year":"2016","unstructured":"Piscuoglio S, Ng CK, Murray M, Burke KA, Edelweiss M, Geyer FC, et al. Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression. J Pathol. 2016;238:508\u201318.","journal-title":"J Pathol"},{"key":"82_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, J R, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415\u201321.","journal-title":"Nature"},{"key":"82_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0893-4","volume":"17","author":"R Rosenthal","year":"2016","unstructured":"Rosenthal R, McGranahan N, Herrero J, Taylor BS, Swanton C. deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 2016;17:31.","journal-title":"Genome Biol"},{"key":"82_CR25","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1038\/leu.2016.135","volume":"30","author":"D Juskevicius","year":"2016","unstructured":"Juskevicius D, Lorber T, Gsponer J, Perrina V, Ruiz C, Stenner-Liewen F, et al. Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis. Leukemia. 2016;30:2385\u201395.","journal-title":"Leukemia"},{"key":"82_CR26","doi-asserted-by":"publisher","first-page":"D805","DOI":"10.1093\/nar\/gku1075","volume":"43","author":"SA Forbes","year":"2015","unstructured":"Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, et al. COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2015;43:D805\u201311.","journal-title":"Nucleic Acids Res"},{"key":"82_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/humu.22932","volume":"37","author":"X Liu","year":"2016","unstructured":"Liu X, Wu C, Li C, Boerwinkle E. dbNSFPv3.0: a one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs. Hum Mutat. 2016;37:235\u201341.","journal-title":"Hum Mutat"},{"key":"82_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/his.13015","volume":"70","author":"M Brand van den","year":"2017","unstructured":"van den Brand M, Rijntjes J, Hebeda KM, Menting L, Bregitha CV, Stevens WBCC. et al. Recurrent mutations in genes involved in nuclear factor-\u03baB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications. Histopathology. 2017;70:174\u201384.","journal-title":"Histopathology"},{"key":"82_CR29","first-page":"1","volume":"28","author":"F Hamadeh","year":"2014","unstructured":"Hamadeh F, MacNamara SP, Aguilera NS, Swerdlow SH, Cook JR. MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma. Mod Pathol. 2014;28:1\u201311.","journal-title":"Mod Pathol"},{"key":"82_CR30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia. N Engl J Med. 2012;367:826\u201333.","journal-title":"N Engl J Med"},{"key":"82_CR31","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1182\/blood-2013-09-525808","volume":"123","author":"ZR Hunter","year":"2014","unstructured":"Hunter ZR, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. The genomic landscape of Waldenstr\u00f6m macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood. 2014;123:1637\u201346.","journal-title":"Blood"},{"key":"82_CR32","doi-asserted-by":"crossref","first-page":"62627","DOI":"10.18632\/oncotarget.11548","volume":"7","author":"P Johansson","year":"2016","unstructured":"Johansson P, Klein-Hitpass L, Grabellus F, Arnold G, Klapper W, Pf\u00f6rtner R, et al. Recurrent mutations in NF-\u03baB pathway components, KMT2D, and NOTCH1\/2 in ocular adnexal MALT-type marginal zone lymphomas. Oncotarget. 2016;7:62627\u201339.","journal-title":"Oncotarget"},{"key":"82_CR33","doi-asserted-by":"crossref","first-page":"17038","DOI":"10.18632\/oncotarget.14928","volume":"8","author":"H Jung","year":"2017","unstructured":"Jung H, Yoo HY, Lee SH, Shin S, Kim SC, Lee S, et al. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP. Oncotarget. 2017;8:17038\u201349.","journal-title":"Oncotarget"},{"key":"82_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.4933","volume":"243","author":"S Moody","year":"2017","unstructured":"Moody S, Escudero-Ibarz L, Wang M, Clipson A, Ochoa Ruiz E, Dunn-Walters D, et al. Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma. J Pathol. 2017;243:3\u20138.","journal-title":"J Pathol"},{"key":"82_CR35","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1084\/jem.20120910","volume":"209","author":"MJ Kiel","year":"2012","unstructured":"Kiel MJ, Velusamy T, Betz BL, Zhao L, Weigelin HG, Chiang MY, et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med. 2012;209:1553\u201365.","journal-title":"J Exp Med"},{"key":"82_CR36","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/leu.2013.365","volume":"28","author":"N Mart\u00ednez","year":"2014","unstructured":"Mart\u00ednez N, Almaraz C, Vaqu\u00e9 JP, Varela I, Derdak S, Beltran S, et al. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation. Leukemia. 2014;28:1334\u201340.","journal-title":"Leukemia"},{"key":"82_CR37","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","volume":"21","author":"M Parry","year":"2015","unstructured":"Parry M, Rose-Zerilli MJJ, Ljungstr\u00f6m V, Gibson J, Wang J, Walewska R, et al. Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing. Clin Cancer Res. 2015;21:4174\u201383.","journal-title":"Clin Cancer Res"},{"key":"82_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1766-z","volume":"15","author":"J Peveling-Oberhag","year":"2015","unstructured":"Peveling-Oberhag J, Wolters F, D\u00f6ring C, Walter D, Sellmann L, Scholtysik R, et al. Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations. BMC Cancer. 2015;15:773.","journal-title":"BMC Cancer"},{"key":"82_CR39","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1084\/jem.20120904","volume":"209","author":"D Rossi","year":"2012","unstructured":"Rossi D, Trifonov V, Fangazio M, Bruscaggin A, Rasi S, Spina V, et al. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med. 2012;209:1537\u201351.","journal-title":"J Exp Med"},{"key":"82_CR40","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/leu.2014.330","volume":"29","author":"A Clipson","year":"2015","unstructured":"Clipson A, Wang M, De Leval L, Ashton-Key M, Wotherspoon A, Vassiliou G, et al. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype. Leukemia. 2015;29:1177\u201385.","journal-title":"Leukemia"},{"key":"82_CR41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00292-013-1882-y","volume":"34","author":"D Juskevicius","year":"2013","unstructured":"Juskevicius D, Ruiz C, Dirnhofer S, Tzankov A. Cyclin D1-positive diffuse large B-cell lymphomas with CYCLIN D1 gene rearrangements: clinical, morphological, phenotypic and genetic evidence of their existence. Pathologe. 2013;34:585\u2013616.","journal-title":"Pathologe"},{"key":"82_CR42","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1038\/leu.2014.167","volume":"28","author":"P Brunner","year":"2014","unstructured":"Brunner P, Rufle A, Dirnhofer S, Lohri A, Willi N, Cathomas G, et al. Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor. Leukemia. 2014;28:1937\u201340.","journal-title":"Leukemia"},{"key":"82_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/cmb.2006.13.215","volume":"13","author":"D Lipson","year":"2006","unstructured":"Lipson D, Aumann Y, Ben-Dor A, Linial N, Yakhini Z. Efficient calculation of interval scores for DNA copy number data analysis. J Comput Biol. 2006;13:215\u201328.","journal-title":"J Comput Biol"},{"key":"82_CR44","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/ng.3441","volume":"47","author":"LB Alexandrov","year":"2015","unstructured":"Alexandrov LB, Jones PH, Wedge DC, Sale JE, Campbell PJ, Nik-Zainal S, et al. Clock-like mutational processes in human somatic cells. Nat Genet. 2015;47:1402\u20137.","journal-title":"Nat Genet"},{"key":"82_CR45","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature14666","volume":"526","author":"XS Puente","year":"2015","unstructured":"Puente XS, Be\u00e0 S, Vald\u00e9s-Mas R, Villamor N, Guti\u00e9rrez-Abril J, Mart\u00edn-Subero JI, et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature. 2015;526:519\u201324.","journal-title":"Nature"},{"key":"82_CR46","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ng.2856","volume":"46","author":"J Okosun","year":"2014","unstructured":"Okosun J, Bodor C, Wang J, Araf S, Yang CY, Pan C, et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat Genet. 2014;46:176\u201381.","journal-title":"Nat Genet"},{"key":"82_CR47","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1097\/PAS.0b013e3182549b50","volume":"36","author":"M Andrulis","year":"2012","unstructured":"Andrulis M, Penzel R, Weichert W, von Deimling A, Capper D. Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia. Am J Surg Pathol. 2012;36:1796\u2013800.","journal-title":"Am J Surg Pathol"},{"key":"82_CR48","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1182\/blood-2012-06-436329","volume":"121","author":"S Poulain","year":"2013","unstructured":"Poulain S, Roumier C, Decambron A, Renneville A, Herbaux C, Bertrand E, et al. MYD88 L265P mutation in Waldenstrom macroglobulinemia. Blood. 2013;121:4504\u201311.","journal-title":"Blood"},{"key":"82_CR49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1182\/blood-2011-08-371179","volume":"119","author":"E Tiacci","year":"2012","unstructured":"Tiacci E, Schiavoni G, Forconi F, Santi A, Trentin L, Ambrosetti A, et al. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF -V600E mutation. Blood. 2012;119:192\u20135.","journal-title":"Blood"},{"key":"82_CR50","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","volume":"364","author":"E Tiacci","year":"2011","unstructured":"Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364:2305\u201315.","journal-title":"N Engl J Med"},{"key":"82_CR51","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1200\/JCO.2016.71.1556","volume":"35","author":"E Tiacci","year":"2017","unstructured":"Tiacci E, Pettirossi V, Schiavoni G, Falini B. Genomics of hairy cell leukemia. J Clin Oncol. 2017;35:1002\u201310.","journal-title":"J Clin Oncol"},{"key":"82_CR52","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2011-08-368209","volume":"119","author":"L Arcaini","year":"2012","unstructured":"Arcaini L, Zibellini S, Boveri E, Riboni R, Rattotti S, Varettoni M, et al. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood. 2012;119:188\u201392.","journal-title":"Blood"},{"key":"82_CR53","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3324\/haematol.2011.054874","volume":"97","author":"PA Blombery","year":"2012","unstructured":"Blombery PA, Wong SQ, Hewitt CA, Dobrovic A, Maxwell EL, Juneja S, et al. Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders. Haematologica. 2012;97:780\u20133.","journal-title":"Haematologica"},{"key":"82_CR54","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.leukres.2011.12.015","volume":"36","author":"SE Langabeer","year":"2012","unstructured":"Langabeer SE, Quinn F, O\u2019Brien D, McElligott AM, Kelly J, Browne PV, et al. Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia. Leuk Res. 2012;36:483\u20134.","journal-title":"Leuk Res"},{"key":"82_CR55","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00277-017-3145-0","volume":"97","author":"S Haefliger","year":"2018","unstructured":"Haefliger S, Bihl M, Krasniqi F, Tzankov A. PET-positive bone lesion due to Langerhans cell histiocytosis after BEACOPP therapy for Hodgkin lymphoma: how anamnesis, histopathological accuracy, and molecular analysis could resolve a clinical dilemma. Ann Hematol. 2018;97:355\u20137.","journal-title":"Ann Hematol"},{"key":"82_CR56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1309\/AJCP5WVXJ2KTLODO","volume":"144","author":"S Turakhia","year":"2015","unstructured":"Turakhia S, Lanigan C, Hamadeh F, Swerdlow SH, Tubbs RR, Cook JR. Immunohistochemistry for BRAF V600E in the differential diagnosis of hairy cell leukemia vs other splenic B-cell lymphomas. Am J Clin Pathol. 2015;144:87\u201393.","journal-title":"Am J Clin Pathol"},{"key":"82_CR57","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1182\/blood-2013-07-513523","volume":"122","author":"PW Raess","year":"2013","unstructured":"Raess PW, Mintzer D, Husson M, Nakashima MO, Morrissette JJD, Daber R, et al. BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma\/leukemia, a potential mimic of hairy cell leukemia. Blood. 2013;122:3084\u20135.","journal-title":"Blood"},{"key":"82_CR58","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1309\/AJCP5TWORA0TMXGL","volume":"138","author":"JA Laurini","year":"2012","unstructured":"Laurini JA, Aoun P, Iqbal J, Chan W, Greiner TC. Investigation of the BRAF V600E mutation by pyrosequencing in lymphoproliferative disorders. Am J Clin Pathol. 2012;138:877\u201383.","journal-title":"Am J Clin Pathol"},{"key":"82_CR59","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949\u201354.","journal-title":"Nature"},{"key":"82_CR60","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1056\/NEJMoa1112302","volume":"366","author":"JA Sosman","year":"2012","unstructured":"Sosman JA, Kim KB, Schuchter L, Gonzalez R, Pavlick AC, Weber JS, et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med. 2012;366:707\u201314.","journal-title":"N Engl J Med"},{"key":"82_CR61","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1056\/NEJMoa1506583","volume":"373","author":"E Tiacci","year":"2015","unstructured":"Tiacci E, Park JH, De Carolis L, Chung SS, Broccoli A, Scott S, et al. Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia. N Engl J Med. 2015;373:1733\u201347.","journal-title":"N Engl J Med"},{"key":"82_CR62","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature23291","volume":"548","author":"Z Yao","year":"2017","unstructured":"Yao Z, Yaeger R, Rodrik-Outmezguine VS, Tao A, Torres NM, Chang MT, et al. Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS. Nature. 2017;548:234\u20138.","journal-title":"Nature"},{"key":"82_CR63","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1158\/2159-8290.CD-12-0097","volume":"2","author":"KB Dahlman","year":"2012","unstructured":"Dahlman KB, Xia J, Hutchinson K, Ng C, Hucks D, Jia P, et al. BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors. Cancer Discov. 2012;2:791\u20137.","journal-title":"Cancer Discov"},{"key":"82_CR64","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1074-7613(03)00029-3","volume":"18","author":"K Kuroda","year":"2003","unstructured":"Kuroda K, Han H, Tani S, Tanigaki K, Tun T, Furukawa T, et al. Regulation of marginal zone B cell development by MINT, a suppressor of Notch\/RBP-J signaling pathway. Immunity. 2003;18:301\u201312.","journal-title":"Immunity"},{"key":"82_CR65","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S1074-7613(03)00111-0","volume":"18","author":"T Saito","year":"2003","unstructured":"Saito T, Chiba S, Ichikawa M, Kunisato A, Asai T, Shimizu K, et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity. 2003;18:675\u201385.","journal-title":"Immunity"},{"key":"82_CR66","doi-asserted-by":"publisher","first-page":"15454","DOI":"10.1073\/pnas.0702891104","volume":"104","author":"MA Santos","year":"2007","unstructured":"Santos MA, Sarmento LM, Rebelo M, Doce AA, Maillard I, Dumortier A, et al. Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells. Proc Natl Acad Sci USA. 2007;104:15454\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"82_CR67","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nri2656","volume":"9","author":"S Pillai","year":"2009","unstructured":"Pillai S, Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol. 2009;9:767\u201377.","journal-title":"Nat Rev Immunol"},{"key":"82_CR68","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1158\/2159-8290.CD-16-0975","volume":"7","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Ortega-Molina A, Geng H, Ying HY, Hatzi K, Parsa S, et al. CREBBP inactivation promotes the development of HDAC3-dependent lymphomas. Cancer Discov. 2017;7:38\u201353.","journal-title":"Cancer Discov"},{"key":"82_CR69","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/sj.leu.2401708","volume":"14","author":"F Bertoni","year":"2000","unstructured":"Bertoni F, Conconi A, Luminari S, Realini C, Roggero E, Baldini L, et al. Lack of CD95\/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas. Leukemia. 2000;14:446\u20138.","journal-title":"Leukemia"},{"key":"82_CR70","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1071553","volume":"296","author":"H Wajant","year":"2002","unstructured":"Wajant H. The Fas signaling pathway: more than a paradigm. Science. 2002;296:1635\u20136.","journal-title":"Science"},{"key":"82_CR71","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.1182\/blood-2010-01-263145","volume":"115","author":"KC Dowdell","year":"2010","unstructured":"Dowdell KC, Niemela JE, Price S, Davis J, Hornung RL, Oliveira JB, et al. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood. 2010;115:5164\u20139.","journal-title":"Blood"},{"key":"82_CR72","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3415","volume":"47","author":"K Kataoka","year":"2015","unstructured":"Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J-I, et al. Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet. 2015;47:1304\u201315.","journal-title":"Nat Genet"},{"key":"82_CR73","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-15-2123","volume":"22","author":"RD Morin","year":"2016","unstructured":"Morin RD, Assouline S, Alcaide M, Mohajeri A, Johnston RL, Chong L, et al. Genetic landscapes of relapsed and refractory diffuse large B-cell lymphomas. Clin Cancer Res. 2016;22:2290\u2013300.","journal-title":"Clin Cancer Res"},{"key":"82_CR74","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S0002-9440(10)63195-1","volume":"164","author":"S Wohlfart","year":"2004","unstructured":"Wohlfart S, Sebinger D, Gruber P, Buch J, Polgar D, Krupitza G, et al. FAS (CD95) mutations are rare in gastric malt lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma. Am J Pathol. 2004;164:1081\u20139.","journal-title":"Am J Pathol"},{"issue":"7","key":"82_CR75","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.jid.2018.02.015","volume":"138","author":"Katja Maurus","year":"2018","unstructured":"Maurus K, Appenzeller S, Roth S, Kuper J, Rost S, Meierjohann S, et al. Panel sequencing reveals recurrent genetic FAS alterations in primary cutaneous marginal zone lymphoma. J Invest Dermatol. 2018 Feb 23. pii: S0022-202X(18)30138-6. https:\/\/doi.org\/10.1016\/j.jid.2018.02.015 .","journal-title":"Journal of Investigative Dermatology"},{"key":"82_CR76","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/leu.2012.257","volume":"27","author":"N Gachard","year":"2013","unstructured":"Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D, et al. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphomas. Leukemia. 2013;27:183\u20139.","journal-title":"Leukemia"},{"key":"82_CR77","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4161\/cbt.28411","volume":"15","author":"RC Wu","year":"2014","unstructured":"Wu R-C, Wang T-L, Shih I-M. The emerging roles of ARID1A in tumor suppression. Cancer Biol Ther. 2014;15:655\u201364.","journal-title":"Cancer Biol Ther"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0082-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0082-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0082-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:33:46Z","timestamp":1684618426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-018-0082-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":77,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1038\/s41375-018-0082-4","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,28]]},"assertion":[{"value":"31 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}